{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T11:20:16Z","timestamp":1790421616232,"version":"4.1.0"},"reference-count":83,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medical Genetics"],"published-print":{"date-parts":[[2005,4]]},"DOI":"10.1016\/j.ejmg.2005.03.001","type":"journal-article","created":{"date-parts":[[2005,4,14]],"date-time":"2005-04-14T16:48:32Z","timestamp":1113497312000},"page":"81-96","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":125,"title":["Germ-line and somatic PTPN11 mutations in human disease"],"prefix":"10.1016","volume":"48","author":[{"given":"Marco","family":"Tartaglia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce D.","family":"Gelb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmg.2005.03.001_bib1","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1073\/pnas.90.6.2197","article-title":"A widely expressed human protein\u2013tyrosine phosphatase containing src homology 2 domains","volume":"90","author":"Ahmad","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejmg.2005.03.001_bib2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1136\/jmg.24.1.9","article-title":"Noonan syndrome","volume":"24","author":"Allanson","year":"1987","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.ejmg.2005.03.001_bib3","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.cell.2004.05.018","article-title":"Protein tyrosine phosphatases in the human genome","volume":"117","author":"Alonso","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.ejmg.2005.03.001_bib4","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1096\/fj.02-1212rev","article-title":"A genomic perspective on protein tyrosine phosphatases: gene structure, pseudogenes, and genetic disease linkage","volume":"18","author":"Andersen","year":"2004","journal-title":"FASEB J."},{"key":"10.1016\/j.ejmg.2005.03.001_bib5","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/nm1084","article-title":"Mouse model of Noonan syndrome reveals cell type- and gene dosage-dependent effects of Ptpn11 mutation","volume":"10","author":"Araki","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejmg.2005.03.001_bib6","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1182\/blood.V90.2.479","article-title":"Juvenile myelomonocytic leukemia","volume":"90","author":"Aric\u00f2","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.ejmg.2005.03.001_bib7","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0022-3476(97)70273-7","article-title":"Occurrence of myeloproliferative disorder in patients with Noonan syndrome","volume":"130","author":"Bader-Meunier","year":"1997","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ejmg.2005.03.001_bib8","doi-asserted-by":"crossref","first-page":"8816","DOI":"10.1158\/0008-5472.CAN-04-1923","article-title":"Activating mutations of the Noonan syndrome-associated SHP2\/PTPN11 gene in human solid tumors and adult acute myelogenous leukemia","volume":"64","author":"Bentires-Alj","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmg.2005.03.001_bib9","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1590\/S0066-782X2000001100005","article-title":"Cardiac findings in 31 patients with Noonan's syndrome","volume":"75","author":"Bertola","year":"2000","journal-title":"Arq. Bras. Cardiol."},{"key":"10.1016\/j.ejmg.2005.03.001_bib10","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/1096-8628(20010122)98:3<230::AID-AJMG1080>3.0.CO;2-K","article-title":"Are Noonan syndrome and Noonan-like\/multiple giant cell lesion syndrome distinct entities?","volume":"98","author":"Bertola","year":"2001","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.ejmg.2005.03.001_bib11","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1002\/ajmg.a.30270","article-title":"Clinical variability in a Noonan syndrome family with a new PTPN11 gene mutation","volume":"130A","author":"Bertola","year":"2004","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.ejmg.2005.03.001_bib12","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/73528","article-title":"Mice mutant for Egfr and Shp2 have defective cardiac semilunar valvulogenesis","volume":"24","author":"Chen","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ejmg.2005.03.001_bib13","doi-asserted-by":"crossref","first-page":"16520","DOI":"10.1074\/jbc.M210572200","article-title":"Identification of Shp-2 as a Stat5A phosphatase","volume":"278","author":"Chen","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmg.2005.03.001_bib14","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/00043426-199911000-00014","article-title":"Juvenile myelomonocytic leukemia and Noonan syndrome","volume":"21","author":"Choong","year":"1999","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"10.1016\/j.ejmg.2005.03.001_bib15","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/ajmg.1320400208","article-title":"Noonan-like\/multiple giant cell lesion syndrome","volume":"40","author":"Cohen","year":"1991","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.ejmg.2005.03.001_bib16","first-page":"14","article-title":"A new syndrome, and hyperparathyroidism","volume":"2","author":"Cohen","year":"1974","journal-title":"Syndrome Indent."},{"key":"10.1016\/j.ejmg.2005.03.001_bib17","doi-asserted-by":"crossref","first-page":"9498","DOI":"10.1074\/jbc.M110547200","article-title":"Regulation of the mitogen-activated protein kinase signalling pathway by SHP-2","volume":"277","author":"Cunnick","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmg.2005.03.001_bib18","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1002\/humu.9149","article-title":"A novel PTPN11 mutation in LEOPARD syndrome","volume":"21","author":"Conti","year":"2003","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ejmg.2005.03.001_bib19","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1086\/341528","article-title":"Grouping of multiple-lentigines\/LEOPARD and Noonan syndromes on the PTPN11 gene","volume":"71","author":"Digilio","year":"2002","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ejmg.2005.03.001_bib20","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/bdra.10148","article-title":"Familial aggregation of genetically heterogeneous hypertrophic cardiomyopathy: a boy with LEOPARD syndrome due to PTPN11 mutation and his nonsyndromic father lacking PTPN11 mutations","volume":"70","author":"Digilio","year":"2004","journal-title":"Birth Defects Res. Part A Clin. Mol. Teratol."},{"key":"10.1016\/j.ejmg.2005.03.001_bib21","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1136\/jmg.31.6.468","article-title":"Genital tract function in men with Noonan syndrome","volume":"31","author":"Elsawi","year":"1994","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.ejmg.2005.03.001_bib22","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/1357-4310(96)10044-7","article-title":"Juvenile myelomonocitic leukemia: molecular understanding and prospects for therapy","volume":"2","author":"Emanuel","year":"1996","journal-title":"Mol. Med. Today"},{"key":"10.1016\/j.ejmg.2005.03.001_bib23","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/humu.20005","article-title":"Noonan syndrome-associated SHP2\/PTPN11 mutants cause EGF-dependent prolonged GAB1 binding and sustained ERK2\/MAPK1 activation","volume":"23","author":"Fragale","year":"2004","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ejmg.2005.03.001_bib24","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1001\/archpedi.1969.02100030654006","article-title":"Multiple lentigines syndrome","volume":"117","author":"Gorlin","year":"1969","journal-title":"Am. J. Dis. Child."},{"key":"10.1016\/j.ejmg.2005.03.001_bib25","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0092-8674(00)80938-1","article-title":"Crystal structure of the tyrosine phosphatase SHP-2","volume":"92","author":"Hof","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.ejmg.2005.03.001_bib26","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1021\/bi9722913","article-title":"The specificity of the N-terminal SH2 domain of SHP-2 is modified by a single point mutation","volume":"37","author":"Huyer","year":"1998","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmg.2005.03.001_bib27","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s00439-002-0803-6","article-title":"Absence of PTPN11 mutations in 28 cases of cardiofaciocutaneous (CFC) syndrome","volume":"111","author":"Ion","year":"2002","journal-title":"Hum. Genet."},{"key":"10.1016\/j.ejmg.2005.03.001_bib28","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/ng1294-357","article-title":"Mapping a gene for Noonan syndrome to the long arm of chromosome 12","volume":"8","author":"Jamieson","year":"1994","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ejmg.2005.03.001_bib29","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/j.1365-2141.2004.04862.x","article-title":"Mutations in PTPN11 are uncommon in adult myelodysplastic syndromes and acute myeloid leukaemia","volume":"124","author":"Johan","year":"2004","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.ejmg.2005.03.001_bib30","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/sj.ejhg.5200911","article-title":"PTPN11 mutations are not responsible for the Cardiofaciocutaneous (CFC) syndrome","volume":"11","author":"Kavamura","year":"2003","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.ejmg.2005.03.001_bib31","doi-asserted-by":"crossref","first-page":"e117","DOI":"10.1136\/jmg.2004.021451","article-title":"PTPN11 mutations in patients with LEOPARD syndrome: a French multicentric experience","volume":"41","author":"Keren","year":"2004","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.ejmg.2005.03.001_bib32","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1007\/s00431-003-1227-6","article-title":"Noonan syndrome with leukaemoid reaction and overproduction of catecholamines: a case report","volume":"162","author":"Kondoh","year":"2003","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.ejmg.2005.03.001_bib33","doi-asserted-by":"crossref","first-page":"3529","DOI":"10.1210\/jcem.87.8.8694","article-title":"PTPN11 (protein\u2013tyrosine phosphatase, nonreceptor-type 11) mutations in seven Japanese patients with Noonan syndrome","volume":"87","author":"Kosaki","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ejmg.2005.03.001_bib34","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0969-2126(00)00044-7","article-title":"Crystal structures of peptide complexes of the amino-terminal SH2 domain of the Syp tyrosine phosphatase","volume":"2","author":"Lee","year":"1994","journal-title":"Structure"},{"key":"10.1016\/j.ejmg.2005.03.001_bib35","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1136\/jmg.2004.024091","article-title":"Phenotypic and genotypic characterization of Noonan-like\/multiple giant cell lesion syndrome","volume":"42","author":"Lee","year":"2005","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.ejmg.2005.03.001_bib36","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/prot.20296","article-title":"Noonan syndrome type I with PTPN11 3\u00a0bp deletion: structure\u2013function implications","volume":"58","author":"Lee","year":"2005","journal-title":"Proteins"},{"key":"10.1016\/j.ejmg.2005.03.001_bib37","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/sj.ejhg.5200150","article-title":"Fine mapping of Noonan\/cardio-facio cutaneous syndrome in a large family","volume":"6","author":"Legius","year":"1998","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.ejmg.2005.03.001_bib38","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1136\/jmg.39.8.571","article-title":"PTPN11 mutations in LEOPARD syndrome","volume":"39","author":"Legius","year":"2002","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.ejmg.2005.03.001_bib39","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.leukres.2004.10.001","article-title":"Acquired PTPN11 mutations occur rarely in adult patients with myelodysplastic syndromes and chronic myelomonocytic leukemia","volume":"29","author":"Loh","year":"2005","journal-title":"Leuk. Res."},{"key":"10.1016\/j.ejmg.2005.03.001_bib40","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1038\/sj.leu.2403492","article-title":"PTPN11 mutations in pediatric patients with acute myeloid leukemia: results from the Children's Cancer Group","volume":"18","author":"Loh","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.ejmg.2005.03.001_bib41","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1182\/blood-2003-09-3287","article-title":"Mutations in PTPN11 implicate the SHP-2 phosphatase in leukemogenesis","volume":"103","author":"Loh","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.ejmg.2005.03.001_bib42","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/humu.10129","article-title":"PTPN11 Mutations in Noonan syndrome type I: detection of recurrent mutations in exons 3 and 13","volume":"20","author":"Maheshwari","year":"2002","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ejmg.2005.03.001_bib43","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S0022-3476(99)70088-0","article-title":"Congenital heart diseases in children with Noonan syndrome: an expanded cardiac spectrum with high prevalence of atrioventricular canal","volume":"135","author":"Marino","year":"1999","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ejmg.2005.03.001_bib44","doi-asserted-by":"crossref","first-page":"8513","DOI":"10.1128\/MCB.20.22.8513-8525.2000","article-title":"The tyrosine phosphatase SHP-2 is required for sustained activation of extracellular signal-regulated kinase and epithelial morphogenesis downstream from the met receptor tyrosine kinase","volume":"20","author":"Maroun","year":"2000","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ejmg.2005.03.001_bib45","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/sj.ejhg.5200935","article-title":"Spectrum of mutations in PTPN11 and genotype\u2013phenotype correlation in 96 patients with Noonan syndrome and five patients with cardio-facio-cutaneous syndrome","volume":"11","author":"Musante","year":"2003","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.ejmg.2005.03.001_bib46","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1001\/archpedi.1968.02100020377005","article-title":"Hypertelorism with Turner phenotype. A new syndrome with associated congenital heart disease","volume":"116","author":"Noonan","year":"1968","journal-title":"Am. J. Dis. Child."},{"key":"10.1016\/j.ejmg.2005.03.001_bib47","first-page":"468","article-title":"Associated non cardiac malformations in children with congenital heart disease","volume":"63","author":"Noonan","year":"1963","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ejmg.2005.03.001_bib48","first-page":"48","article-title":"The Ullrich\u2013Noonan syndrome (Turner phenotype)","volume":"127","author":"Nora","year":"1974","journal-title":"Am. J. Dis. Child."},{"key":"10.1016\/j.ejmg.2005.03.001_bib49","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1128\/MCB.20.1.299-311.2000","article-title":"Activated mutants of SHP-2 preferentially induce elongation of Xenopus animal caps","volume":"20","author":"O'Reilly","year":"2000","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ejmg.2005.03.001_bib50","doi-asserted-by":"crossref","first-page":"5499","DOI":"10.1128\/MCB.17.9.5499","article-title":"A deletion mutation in the SH2-N domain of Shp-2 severely suppresses hematopoietic cell development","volume":"17","author":"Qu","year":"1997","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ejmg.2005.03.001_bib51","doi-asserted-by":"crossref","first-page":"6075","DOI":"10.1128\/MCB.18.10.6075","article-title":"Biased suppression of hematopoiesis and multiple developmental defects in chimeric mice containing Shp-2 mutant cells","volume":"18","author":"Qu","year":"1998","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ejmg.2005.03.001_bib52","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1182\/blood.V97.4.911","article-title":"Requirement of Shp-2 tyrosine phosphatase in lymphoid and hematopoietic cell development","volume":"97","author":"Qu","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.ejmg.2005.03.001_bib53","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1136\/jmg.40.9.704","article-title":"Correlation between PTPN11 gene mutations and congenital heart defects in Noonan and LEOPARD syndromes","volume":"40","author":"Sarkozy","year":"2003","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.ejmg.2005.03.001_bib54","doi-asserted-by":"crossref","first-page":"e68","DOI":"10.1136\/jmg.2003.013466","article-title":"Clinical and molecular analysis of 30 patients with multiple lentigines LEOPARD syndrome","volume":"41","author":"Sarkozy","year":"2004","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.ejmg.2005.03.001_bib55","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/sj.ejhg.5201290","article-title":"A novel PTPN11 gene mutation bridges Noonan syndrome, multiple lentigines\/LEOPARD syndrome and Noonan-like\/multiple giant cell lesion syndrome","volume":"12","author":"Sarkozy","year":"2004","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.ejmg.2005.03.001_bib56","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1093\/emboj\/16.9.2352","article-title":"Abnormal mesoderm patterning in mouse embryos mutant for the SH2 tyrosine phosphatase Shp-2","volume":"16","author":"Saxton","year":"1997","journal-title":"EMBO J."},{"key":"10.1016\/j.ejmg.2005.03.001_bib57","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/74279","article-title":"The SH2 tyrosine phosphatase shp2 is required for mammalian limb development","volume":"24","author":"Saxton","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ejmg.2005.03.001_bib58","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1136\/adc.67.2.178","article-title":"A clinical study of Noonan syndrome","volume":"67","author":"Sharland","year":"1992","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.ejmg.2005.03.001_bib59","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1128\/MCB.20.5.1526-1536.2000","article-title":"Molecular mechanism for the Shp-2 tyrosine phosphatase function in promoting growth factor stimulation of Erk activity","volume":"20","author":"Shi","year":"2000","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ejmg.2005.03.001_bib60","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1038\/sj.leu.2403374","article-title":"Somatic PTPN11 mutation with a heterogeneous clonal origin in children with juvenile myelomonocytic leukemia","volume":"18","author":"Shimada","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.ejmg.2005.03.001_bib61","first-page":"259","article-title":"PTPN11 mutation in a young man with Noonan syndrome and retinitis pigmentosa","volume":"14","author":"Schollen","year":"2003","journal-title":"Genet. Couns."},{"key":"10.1016\/j.ejmg.2005.03.001_bib62","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/0092-8674(95)90498-0","article-title":"The SH2-containing protein\u2013tyrosine phosphatase SH-PTP2 is required upstream of MAP kinase for early Xenopus development","volume":"80","author":"Tang","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.ejmg.2005.03.001_bib63","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/ng772","article-title":"Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome","volume":"29","author":"Tartaglia","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ejmg.2005.03.001_bib64","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1086\/340847","article-title":"PTPN11 mutations in Noonan syndrome: molecular spectrum, genotype\u2013phenotype correlation, and phenotypic heterogeneity","volume":"70","author":"Tartaglia","year":"2002","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ejmg.2005.03.001_bib65","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1034\/j.1399-0004.2003.00076.x","article-title":"Exclusion of PTPN11 mutations in Costello syndrome: further evidence for distinct genetic etiologies of Noonan, cardio-facio-cutaneous, and Costello syndromes","volume":"63","author":"Tartaglia","year":"2003","journal-title":"Clin. Genet."},{"key":"10.1016\/j.ejmg.2005.03.001_bib66","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/ng1156","article-title":"Somatic mutations in PTPN11 in juvenile myelomonocytic leukemia, myelodysplastic syndromes and acute myeloid leukemia","volume":"34","author":"Tartaglia","year":"2003","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ejmg.2005.03.001_bib67","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1086\/423493","article-title":"Paternal germline origin and sex-ratio distortion in transmission of PTPN11 mutations in Noonan syndrome","volume":"75","author":"Tartaglia","year":"2004","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ejmg.2005.03.001_bib68","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1182\/blood-2003-11-3876","article-title":"Genetic evidence for lineage- and differentiation stage-related contribution of somatic PTPN11 mutations to leukemogenesis in childhood acute leukemia","volume":"104","author":"Tartaglia","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.ejmg.2005.03.001_bib69","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/ajmg.a.20122","article-title":"No mutation in the gene for Noonan syndrome, PTPN11, in 18 patients with Costello syndrome","volume":"121A","author":"Troger","year":"2003","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.ejmg.2005.03.001_bib70","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/1096-8628(20000904)94:1<46::AID-AJMG10>3.0.CO;2-I","article-title":"Genetic heterogeneity in Noonan syndrome: evidence for an autosomal recessive form","volume":"94","author":"Van Der Burgt","year":"2000","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.ejmg.2005.03.001_bib71","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/0002-9343(76)90764-6","article-title":"Multiple lentigines syndrome: case report and review of the literature","volume":"60","author":"Voron","year":"1976","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ejmg.2005.03.001_bib72","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/ajh.20134","article-title":"Mutations in PTPN11 are rare in adult myelodysplastic syndromes and acute myeloid leukemia","volume":"76","author":"Watkins","year":"2004","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.ejmg.2005.03.001_bib73","doi-asserted-by":"crossref","first-page":"6018","DOI":"10.1038\/sj.onc.1204699","article-title":"The tyrosine phosphatase SHP-2 is required for mediating phosphatidylinositol 3-kinase\/Akt activation by growth factors","volume":"20","author":"Wu","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.ejmg.2005.03.001_bib74","doi-asserted-by":"crossref","first-page":"6516","DOI":"10.1074\/jbc.M210430200","article-title":"Crystal structure of human protein\u2013tyrosine phosphatase SHP-1","volume":"278","author":"Yang","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmg.2005.03.001_bib75","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.1210\/jc.2003-032091","article-title":"Protein\u2013tyrosine phosphatase, non-receptor type 11 mutation analysis and clinical assessment in 45 patients with Noonan syndrome","volume":"89","author":"Yoshida","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ejmg.2005.03.001_bib76","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/ajmg.a.30029","article-title":"A 3-bp deletion mutation of PTPN11 in an infant with severe Noonan syndrome including hydrops fetalis and juvenile myelomonocytic leukemia","volume":"128A","author":"Yoshida","year":"2004","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.ejmg.2005.03.001_bib77","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/ajmg.a.30281","article-title":"Two novel and one recurrent PTPN11 mutations in LEOPARD syndrome","volume":"130A","author":"Yoshida","year":"2004","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.ejmg.2005.03.001_bib78","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1128\/MCB.19.3.2416","article-title":"Shp-2 tyrosine phosphatase functions as a negative regulator of the interferon-stimulated Jak\/STAT pathway","volume":"19","author":"You","year":"1999","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ejmg.2005.03.001_bib79","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1084\/jem.193.1.101","article-title":"Modulation of the nuclear factor kappa B pathway by Shp-2 tyrosine phosphatase in mediating the induction of interleukin (IL)-6 by IL-1 or tumor necrosis factor","volume":"193","author":"You","year":"2001","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ejmg.2005.03.001_bib80","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.jpeds.2003.11.032","article-title":"Genotype\u2013phenotype correlations in Noonan syndrome","volume":"144","author":"Zenker","year":"2004","journal-title":"J. Pediatr."},{"key":"10.1016\/j.ejmg.2005.03.001_bib81","doi-asserted-by":"crossref","first-page":"16064","DOI":"10.1073\/pnas.0405041101","article-title":"Neuronal Shp2 tyrosine phosphatase controls energy balance and metabolism","volume":"101","author":"Zhang","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejmg.2005.03.001_bib82","doi-asserted-by":"crossref","first-page":"4062","DOI":"10.1128\/MCB.22.12.4062-4072.2002","article-title":"Receptor-specific regulation of phosphatidylinositol 3'-kinase activation by the protein tyrosine phosphatase Shp2","volume":"22","author":"Zhang","year":"2002","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.ejmg.2005.03.001_bib83","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S1097-2765(04)00050-4","article-title":"Shp2 regulates SRC family kinase activity and Ras\/Erk activation by controlling Csk recruitment","volume":"13","author":"Zhang","year":"2004","journal-title":"Mol. Cell"}],"container-title":["European Journal of Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769721205000534?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769721205000534?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:34:54Z","timestamp":1761708894000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1769721205000534"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4]]},"references-count":83,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,4]]}},"alternative-id":["S1769721205000534"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmg.2005.03.001","relation":{},"ISSN":["1769-7212"],"issn-type":[{"value":"1769-7212","type":"print"}],"subject":[],"published":{"date-parts":[[2005,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Germ-line and somatic PTPN11 mutations in human disease","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medical Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmg.2005.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}